Blue Jet Healthcare Limited (IN:BLUEJET)
:BLUEJET
Want to see IN:BLUEJET full AI Analyst Report?
BLUEJET Stock Chart & Stats
₹653.45
-₹16.80(-2.80%)
At close: 4:00 PM EST
₹653.45
-₹16.80(-2.80%)
Day’s Range― - ―
52-Week Range₹325.20 - ₹1,028.20
Previous CloseN/A
Volume75.53K
Average Volume (3M)19.19K
Market Cap
₹78.42B
Enterprise Value₹76.88B
Total Cash (Recent Filing)₹4.11B
Total Debt (Recent Filing)₹206.29M
Price to Earnings (P/E)31.3
Beta1.33
Next Earnings
Aug 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.22%
Share Statistics
EPS (TTM)20.33
Shares Outstanding173,465,420
10 Day Avg. Volume15,409
30 Day Avg. Volume19,187
Financial Highlights & Ratios
PEG Ratio-1.22
Price to Book (P/B)4.17
Price to Sales (P/S)5.99
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹370.00Price Target Upside-43.38% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering1
EPS Forecast (FY)18.33
Revenue Forecast (FY)₹11.97B
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet With Very Low LeverageExtremely low debt and a steadily expanding equity base give the company durable financial flexibility. This conservatism reduces solvency risk, supports investment or acquisitions without refinancing pressure, and cushions operations through industry cycles over the next 2–6 months.
High And Consistent Gross/net MarginsSustained net margins near mid-20s reflect structural pricing power and operational efficiency in niche API manufacturing. These margins support internal funding for capex, quality systems and R&D, helping maintain competitiveness and profitability across medium-term industry cycles.
Niche, Complex-chemistry API SpecializationSpecialization in complex chemistries and niche APIs creates higher barriers to entry and technical differentiation. This supports durable customer relationships, potential long-term contracts and pricing stability versus commoditized suppliers, reinforcing steady demand over coming months.
Bears Say
Sharp FY2026 Revenue Decline And Choppy Growth ProfileA near-20% top-line drop in FY2026 signals meaningful demand, mix or execution issues that can persist across quarters. For a specialized API maker, sustained revenue weakness reduces leverage from fixed-cost base, pressures margins and limits reinvestment capacity over the next several months.
Volatile Free Cash Flow And Inconsistent Cash ConversionLarge swings in free cash flow undermine predictability of internal funding for capex, working capital and shareholder returns. Inconsistent FCF increases reliance on operational recovery or external financing if investment needs arise, raising execution risk over a 2–6 month horizon.
Operating Cash Flow Weakness Tied To Working-capital TimingWhen operating cash flow lags earnings due to working-capital swings, the business is exposed to timing and customer/payment risks. This can constrain liquidity for suppliers and capex, and it increases the chance of recurring cash squeezes in near-term quarters absent smoother collections or inventory control.
Blue Jet Healthcare Limited News
BLUEJET FAQ
What was Blue Jet Healthcare Limited’s price range in the past 12 months?
Blue Jet Healthcare Limited lowest stock price was ₹325.20 and its highest was ₹1028.20 in the past 12 months.
What is Blue Jet Healthcare Limited’s market cap?
Blue Jet Healthcare Limited’s market cap is ₹78.42B.
When is Blue Jet Healthcare Limited’s upcoming earnings report date?
Blue Jet Healthcare Limited’s upcoming earnings report date is Aug 11, 2026 which is in 68 days.
How were Blue Jet Healthcare Limited’s earnings last quarter?
Blue Jet Healthcare Limited released its earnings results on May 25, 2026. The company reported ₹3.7 earnings per share for the quarter, beating the consensus estimate of ₹2.55 by ₹1.15.
Is Blue Jet Healthcare Limited overvalued?
According to Wall Street analysts Blue Jet Healthcare Limited’s price is currently Overvalued.
Does Blue Jet Healthcare Limited pay dividends?
Blue Jet Healthcare Limited pays a Notavailable dividend of ₹1.2 which represents an annual dividend yield of 0.22%. See more information on Blue Jet Healthcare Limited dividends here
What is Blue Jet Healthcare Limited’s EPS estimate?
Blue Jet Healthcare Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Blue Jet Healthcare Limited have?
Blue Jet Healthcare Limited has 173,465,420 shares outstanding.
What happened to Blue Jet Healthcare Limited’s price movement after its last earnings report?
Blue Jet Healthcare Limited reported an EPS of ₹3.7 in its last earnings report, beating expectations of ₹2.55. Following the earnings report the stock price went up 9.522%.
Which hedge fund is a major shareholder of Blue Jet Healthcare Limited?
Currently, no hedge funds are holding shares in IN:BLUEJET
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Blue Jet Healthcare Limited
Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for applications in pharmaceutical and healthcare products. It provides integrated contrast media intermediates, saccharin and related salts, and niche pharmaceutical intermediates and APIs, as well as CDMO/CMO and development services. Blue Jet Healthcare Limited has operations in India, Norway, the United States, Sweden, Italy, Spain, and internationally. The company was incorporated in 1968 and is headquartered in Thane, India.
BLUEJET Stock 12 Month Forecast
Average Price Target
₹370.00
▼(-43.38% Downside)
Technical Analysis
Biocon Limited
―
Concord Biotech Ltd.
―
Jubilant Ingrevia Ltd.
―
Supriya Lifescience Limited
―
Syngene International Ltd.
―